A glucose antimetabolite and an inhibitor of glycolysis
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

2-deoxy-D-Glucose

Item No. 14325

Technical Information
Formal Name
2-deoxy-D-arabino-hexose
CAS Number
154-17-6
Synonyms
  • Ba 2758
  • 2-DG
  • NSC 15193
Molecular Formula
C6H12O5
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 10 mg/mlDMSO: 20 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
O[C@@H]1[C@@H](CO)OC(O)C[C@H]1O
InChi Code
InChI=1S/C6H12O5/c7-2-4-6(10)3(8)1-5(9)11-4/h3-10H,1-2H2/t3-,4-,5?,6+/m1/s1
InChi Key
PMMURAAUARKVCB-CERMHHMHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    2-deoxy-D-Glucose is a glucose antimetabolite and an inhibitor of glycolysis.1,2 It is metabolized by hexokinase into 2-deoxy-D-glucose-6-phosphate (2-DG6P), which cannot be metabolized by glucose-6-phosphate isomerase, leading to 2-DG6P accumulation, inhibition of glycolysis, and cell death.3 2-deoxy-D-glucose (16 mM) induces apoptosis in SK-BR-3 cells, as well as inhibits the growth of 143B osteosarcoma cells cultured under hypoxic conditions when used at a concentration of 2 mg/ml.4,5 In vivo, 2-deoxy-D-glucose (500 mg/kg) reduces tumor growth in 143B osteosarcoma and MV522 non-small cell lung cancer mouse xenograft models when used alone or in combination with doxorubicin (Item No. 15007) or paclitaxel (Item No. 10461).6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kang, H.T., and Hwang, E.S. 2-Deoxyglucose: An anticancer and antiviral therapeutic, but not any more a low glucose mimetic. Life Sci. 78(12), 1392-1399 (2006).

    2. Aft, R.L., Zhang, F.W., and Gius, D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: Mechanism of cell death. Br. J. Cancer 87(7), 805-812 (2002).

    3. Pajak, B., Siwiak, E., Sołtyka, M., et al2-deoxy-d-glucose and its analogs: From diagnostic to therapeutic agents. Int. J. Mol. Sci. 21(1), 234 (2019).

    4. Liu, H., Savaraj, N., Priebe, W., et alHypoxia increases tumor cell sensitivity to glycolytic inhibitors: A strategy for solid tumor therapy (Model C). Biochem. Pharmacol. 64(12), 1745-1751 (2002).

    5. Zhang, X.D., Deslandes, E., Villedieu, M., et alEffect of 2-deoxy-D-glucose on various malignant cell lines in vitro. Anticancer Res. 26(5A), 3561-3566 (2006).

    6. Maschek, G., Savaraj, N., Priebe, W., et al2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 64(1), 31-34 (2004).

    Product Citations

    Kremer, D.M., Nelson, B.S., Lin, L., et alGOT1 inhibition primes pancreatic cancer for ferroptosis through the autophagic release of labile iron. bioRxiv (2020).

    Bessho, R., Davidoff, O., Kobayashi, H., et alRegional metabolic analysis of structurally preserved kidney slices by ex vivo respirometry. Am. J. Physiol. Renal Physiol. 329(6), F796-F808 (2025).